Clinical Trial Update: Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating topical apraclonidine for ocular synkinesis associated with facial nerve palsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Nerve Palsy
• Ocular Synkinesis

Drugs mentioned

• Apraclonidine (topical ophthalmic solution) (apraclonidine)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Synkinesis, Facial Nerve Palsy | Phase 4 | Status: WITHDRAWN